CMS unveils new investment model to advance ACOs

Laura Pedulli | | Health Exec | Economics

The Centers for Medicare & Medicaid Services has launched a new initiative to encourage new accountable care organizations (ACOs) to form in rural and underserved areas and current Medicare Shared Saving Program (MSSP) ACOs to transition to arrangements with greater financial risk.

CMS’ ACO Investment Model was developed to allay concerns that providers lack adequate capital to implement population care management by providing support to certain ACOS for infrastructure investments. In total, the effort will provide $114 million in funding. The agency will lend support to two distinct groups:

  • New MSSP ACOs joining in 2016 – The model seeks to encourage ACOs in rural areas with little or no ACO activity by offering pre-payment of shared savings both upfront and ongoing per beneficiary per month payments.
  • ACOs that joined MSSP in 2002, 2013 and 2014 – To help ACOs succeed and encourage progression to higher levels of financial risk.

Learn more about eligibility criteria. Applications will be accepted between Oct. 15 and Dec. 1.

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.